Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic In Vitro Hollow-Fiber Infection Model.
Heffernan AJ, Sime FB, Sarovich DS, Neely M, Guerra-Valero Y, Naicker S, Cottrell K, Harris P, Andrews KT, Ellwood D, Wallis SC, Lipman J, Grimwood K, Roberts JA. Heffernan AJ, et al. Among authors: naicker s. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00879-20. doi: 10.1128/AAC.00879-20. Print 2020 Aug 20. Antimicrob Agents Chemother. 2020. PMID: 32660986 Free PMC article.
Pharmacodynamics of once- versus twice-daily dosing of nebulized amikacin in an in vitro Hollow-Fiber Infection Model against 3 clinical isolates of Pseudomonas aeruginosa.
Heffernan AJ, Sime FB, Naicker S, Andrews K, Ellwood D, Guerra-Valero Y, Wallis S, Lipman J, Grimwood K, Roberts JA. Heffernan AJ, et al. Among authors: naicker s. Diagn Microbiol Infect Dis. 2021 Jun;100(2):115329. doi: 10.1016/j.diagmicrobio.2021.115329. Epub 2021 Feb 6. Diagn Microbiol Infect Dis. 2021. PMID: 33714790
300 results